ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$173.08
*  
5.11
3.04%
Get ALXN Alerts
*Delayed - data as of Jul. 23, 2014  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alexion Pharmaceuticals: 4 Different Insiders Have Sold Shares During The Last 30 Days
6/16/2014 10:35:00 AM - Seeking Alpha

Shire to Conduct Trials on Vyvanse on FDA's Request - Analyst Blog
6/13/2014 6:25:00 PM - Zacks.com

AstraZeneca Boosts Pipeline with $232 Million Synairgen Deal - Analyst Blog
6/13/2014 6:20:00 PM - Zacks.com

Vertex Pharmaceuticals' New Kalydeco Data Out - Analyst Blog
6/13/2014 4:10:00 PM - Zacks.com

Stunning Potential For Upside In Canadian Biotech: Brian Bloom
6/13/2014 10:15:00 AM - Seeking Alpha

Bayer Looking to Expand Eylea's Label - Analyst Blog
6/12/2014 5:00:00 PM - Zacks.com

Roche's HPV Test Approved in Canada - Analyst Blog
6/12/2014 11:40:00 AM - Zacks.com

Encouraging Long-Term Data on Celgene's Otezla - Analyst Blog
6/12/2014 11:30:00 AM - Zacks.com

Alkermes Progresses with its Late Stage Candidate - Analyst Blog
6/11/2014 5:00:00 PM - Zacks.com

NPS Pharma's Natpara Likely to be Reviewed in September - Analyst Blog
6/11/2014 4:30:00 PM - Zacks.com

Allergan Rejects Valeant's Proposal Yet Again - Analyst Blog
6/11/2014 11:50:00 AM - Zacks.com

PDL BioPharma Views Lower Q2 Revenues - Analyst Blog
6/11/2014 11:27:00 AM - Zacks.com

Immunomedics' IMMU-132 Gets Orphan Drug Status - Analyst Blog
6/10/2014 6:10:00 PM - Zacks.com

Valeant's Jublia Approved in the U.S. - Analyst Blog
6/10/2014 5:50:00 PM - Zacks.com

Dendreon's CEO Departs at Critical Juncture - Analyst Blog
6/10/2014 5:20:00 PM - Zacks.com

Agios Initiates Trial on AG-348 - Analyst Blog
6/10/2014 4:35:00 PM - Zacks.com

Alexion To Present At Goldman Sachs Conference; Webcast At 11:40 AM ET
6/10/2014 10:40:00 AM - RTT News

Alexion Pharma To Present At William Blair Conference; Webcast At 10:30 AM ET
6/10/2014 9:30:00 AM - RTT News

GW Pharma Gets Fast-Track Designation for Epidiolex - Analyst Blog
6/9/2014 5:40:00 PM - Zacks.com

Pipeline Progress at GlaxoSmithKline - Analyst Blog
6/6/2014 11:26:00 AM - Zacks.com

MannKind Hits 52-Week High - Analyst Blog
6/6/2014 8:00:00 AM - Zacks.com

Positive Phase IIb Data from Jazz Pharma - Analyst Blog
6/5/2014 6:56:00 PM - Zacks.com

Halozyme Study Clinical Hold Lifted by FDA - Analyst Blog
6/5/2014 6:26:00 PM - Zacks.com

Positive Data on Vertex Pharma's Kalydeco - Analyst Blog
6/5/2014 4:45:00 PM - Zacks.com

Nasdaq 100 Movers: ROST, ILMN
6/5/2014 11:46:16 AM - BNK Invest